Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Surgery with Islet Autotransplantation for Patients with Pancreatic Cancer

Official title: Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation (IAtx) in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula (POPF)

Run by Technische Universität Dresden · NCT05843877 · Data updated 2026-11-12

This study is testing if a surgery that includes removing the whole pancreas and transplanting the patient's own insulin-producing cells can help people with pancreatic cancer avoid complications and start treatment faster compared to just removing part of the pancreas.

More Periampullary Cancer trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment32 (estimated)
SponsorTechnische Universität Dresden
Academic / other
Locations1 site (Dresden)
StatusRecruiting
StartedJanuary 28, 2025
Main results expectedJanuary 2028
Study endsJanuary 2028
Registry record updatedJanuary 30, 2026
Trial IDNCT05843877 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with suspected or confirmed periampullary carcinoma who are at high risk for postoperative pancreatic fistula.

Probably not a fit

Patients with other primary tumors, those requiring additional simultaneous procedures, or those with certain infections or diabetes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of total pancreatectomy combined with islet autotransplantation compared to pancreatic head resection alone in patients with periampullary cancer who are at high risk for developing postoperative pancreatic fistulas. The study aims to reduce perioperative complications and expedite the start of adjuvant therapy. Participants will undergo either a classic Whipple procedure or pylorus-preserving pancreaticoduodenectomy, followed by the transplantation of their own pancreatic islets. The trial focuses on patients with specific anatomical and health profiles that increase their risk for complications.

Why it matters

Potential benefit: If successful, this approach could significantly reduce complications and improve recovery times for patients undergoing surgery for periampullary cancer.

How similar studies have gone: While similar approaches have been explored, this specific combination of total pancreatectomy with islet autotransplantation in this patient population is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* suspected or confirmed periampullary carcinoma (tumor) and indication for PPPD (pylorus-preserving pancreaticoduodenectomy) or Whipple surgery
* high-risk profile for the development of a postoperative pancreatic fistula (POPF) after pancreatic head resection: soft pancreas and Pancreatic duct diameter \< 3 mm (preoperative and intraoperative confirmation)
* written informed consent of the participant after successful Informed consent

Exclusion Criteria:

* patients on whom another procedure is to be performed simultaneously in addition to PPPD or Whipple surgery
* confirmed other primary tumor
* previous transplantation of an organ or tissue
* known infection with HIV (HIV antibodies)
* positive hepatitis C antibodies, positive hepatitis B surface antigens and hepatitis Bc antibodies
* insulin-treated diabetes mellitus
* history of hypersensitivity to any of the drugs used or their ingredients or to drugs with a similar chemical structure
* concurrent participation in another clinical trial (incl. within the last 4 weeks prior to inclusion).
* addiction or other medical conditions that do not allow the subject to understand the nature and not be able to appreciate the nature, scope and possible consequences of the trial
* pregnant or breastfeeding women
* women of childbearing age, except for women who meet the following criteria:

  1. Post-menopausal (12 months of natural amenorrhea or 6 months of amenorrhea with Serum FSH \> 40 U/ml)
  2. Post-operative (6 weeks after bilateral ovariectomy with or without hysterectomy)
  3. Regular and correct use of a contraceptive method with an failure rate \< 1% per year
  4. Sexual abstinence
  5. Vasectomy of the partner
* evidence that the patient is unlikely to comply with the protocol

Where it's running

  • University Hospital Carl Gustav Carus Technische Universität Dresden
    Dresden, Germany
    Recruiting

Study contacts

  • Principal investigator: Barbara Ludwig, Prof. Dr. — Department of internal Medicine III
  • Study coordinator: Barbara Ludwig, Prof. Dr.
  • Email: barbara.ludwig@ukdd.de
  • Phone: +49 458

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.